KB407
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Krystal Biotech, Inc.
Overview
KB407 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
KB407 clinical trials
Explore related
Medical disclaimer. This page summarizes research about KB407 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.